medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2003, Número 1

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2003; 50 (1)


Síndrome de anticuerpos antifosfolípido

Barba EJR

Idioma: Español
Referencias bibliográficas: 31
Paginas: 20-32
Archivo PDF: 105.84 Kb.


RESUMEN

Actualmente el síndrome de anticuerpos antifosfolípido ha adquirido gran interés dadas sus manifestaciones clínicas. El presente trabajo es una recopilación de sus principales características.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. von Scheven E et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 339-345.

  2. Velasco F et al. Síndrome antifosfolípido (SAF): posibles mecanismos patogénicos de trombosis. Sangre 1997; 42(6): 475-481.

  3. Said PB et al. Fisiopatología del síndrome antifosfolípido. Sangre 1993; 38(2): 1131-1138.

  4. Rojas SJ. Revisión síndrome de anticuerpos antifosfolípido. Rev Mex Reumat 1996; 11: 179-185.

  5. Harris EN. Diagnóstico y tratamiento del síndrome antifosfolípido. Ed. Mexicana. Hospital Practice 1995; 4(1): 12-21.

  6. Dunn JP et al. Antiphospholipid antibodies and retinal vascular disease. Lupus 1996; 5: 313-322.

  7. Gharavi AE et al. The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome. Lupus 1996; 5: 343-344.

  8. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.

  9. Alarcón-Segovia D et al. The concept and classification of antiphospholipid/cofactor syndromes. Lupus 1996; 5: 364-367.

  10. Piette JC. Diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a “mission impossible”? Lupus 1996; 5: 354-363.

  11. Levy RA. Clinical manifestations of the aPL syndrome. Lupus 1996; 5: 393-397.

  12. Hughes GRV. The antiphospholipid syndrome. Lupus 1996; 5: 345-346.

  13. Wilson WA et al. Genetic risk factors for aPL syndrome. Lupus 1996; 5: 398-403.

  14. Triplett DA. Lupus anticoagulants/antiphospholipid-protein antibodies: the great imposters. Lupus 1996; 5: 431-435.

  15. Lockshin MD. Antiphospholipid antibody syndrome. Rheumatic Disease Clinics of North America 1994; 20(1): 45-59.

  16. Lockshin MD. Pathogenesis of the antiphospholipid antibody syndrome. Lupus 1996; 5: 404-408.

  17. Machin SJ. Platelets and antiphospholipid antibodies. Lupus 1996; 5: 386-387.

  18. Robbins DL et al. Effect of anticardiolipin/ b2-glycoprotein-1 complexes on production of tromboxane A2 by platelets from patients with the antiphospholipid syndrome. J Rheumatol 1998; 25: 51-56.

  19. Branch DW. Criteria for antiphospolipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996; 5: 409-413.

  20. Levine SR et al. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5: 347-353.

  21. Baca V et al. Cerebral infarction and antiphospholipid syndrome in children. The Journal of Rheumatology 1996; 23: 1428-1431.

  22. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus 1996; 5: 368-371.

  23. Hofbauer LCh et al. Graves disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996; 23: 1435-1437.

  24. Asherson RA. The catastrophic antiphospholipid syndrome 1996: acute multiorgan failure with antiphospholipid antibodies: a review of 31 patients. Lupus 1996; 5: 414-417.

  25. Hanly JG et al. b2-glycoprotein-1 and anticardiolipin antibody binding to resting and activated cultured human endothelial cells. J Rheumatol 1996; 23: 1543-1549.

  26. Kandiah DA et al. b2-glycoprotein-1: target antigen for autoantibodies in the “antiphospholipid syndrome”. Lupus 1996; 5: 381-385.

  27. Tomas JF et al. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998; 25: 57-62.

  28. Roubey RAS. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory and diagnosis of the antiphospholipid syndrome. Lupus 1996; 5: 425-430.

  29. Galli M. Non b2-glycoprotein-1 cofactors for antiphospholipid antibodies. Lupus 1996; 5: 388-392.

  30. Koike T et al. Anti b2-glycoprotein-1 antibody: specificity and clinical significance. Lupus 1996; 5: 378-380.

  31. Harris EN et al. Functional effects of anticardiolipin antibodies. Lupus 1996; 5: 372-377.




2020     |     www.medigraphic.com